T-lymphoblastic inert lymphoma is a serious condition.
T-lymphoblastic inert lymphoma belongs to non-Hodgkin’s lymphoma, the disease progress of this kind of lymphoma patients is slow, and the survival period of the patients is relatively long, but the nature of the disease belongs to the malignant disease of the blood system, and it is difficult to be cured completely. Therefore, the condition of T-lymphoblastic inert lymphoma is serious.
Although the disease of T lymphocyte inert lymphoma progresses slowly, it will continue to progress, so it also needs to be actively treated with targeted therapy (cedarbenazine), combined chemotherapy (cyclophosphamide, vinblastine), or bone marrow transplantation, and the specific treatment plan needs to be formulated according to the specific condition of the patient.
It is recommended that patients with T-lymphoblastic inert lymphoma should consult the hematology department in a timely manner, and complete bone marrow aspiration, bone marrow biopsy, and PET-CT to evaluate their conditions, and then formulate an individualized treatment plan under the guidance of the physician.